1.
JOURNAL OF ALZHEIMER'S DISEASE 36 : 3 pp. 487-501. , 15 p. (2013)
Közlemény:2246475 Egyeztetett Forrás Idéző Folyóiratcikk (Szakcikk ) Nyilvános idézők összesen: 47 Független: 28 Függő: 19 Idézett közlemények száma: 20
Folyóiratcikk/Szakcikk (Folyóiratcikk)/Tudományos[2246475] [Érvényesített]
Független idéző: 28, Függő idéző: 19, Nem vizsgált idéző: 0, Összes idéző: 47
  1. Gosselet F et al. Amyloid-beta Peptides, Alzheimer's Disease and the Blood-brain Barrier. (2013) CURRENT ALZHEIMER RESEARCH 1567-2050 10 10 1015-1033
  2. * Veszelka S et al. Efflux transport of serum amyloid P component at the blood-brain barrier. (2013) EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY 2062-509X 3 4 281-289
  3. He Yarong et al. Cell-Culture Models of the Blood-Brain Barrier. (2014) STROKE 0039-2499 1524-4628 45 8 2514-2526
  4. * Jähne EA et al. Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models. (2014) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 0731-7085 1873-264X 98 235-246
  5. Salmina AB. Konneksinovye i panneksinovye transportnye sistemy v kletkakh neirovaskulyarnoi edinitsy golovnogo mozga. (2014) NEIROKHIMIYA 1027-8133 31 2 122-133
  6. * Sándor N et al. Low dose cranial irradiation-induced cerebrovascular damage is reversible in mice. (2014) PLOS ONE 1932-6203 9 11
  7. Evans AR. Multiplexing Techniques in Qunatitative Proteomics to Study Disease: B.Sc. Thesis, University of Pittsburgh, Pittsburgh, USA. (2014)
  8. Hurtado-Alvarado G et al. Pericytes: brain-immune interface modulators. (2014) FRONTIERS IN INTEGRATIVE NEUROSCIENCE 1662-5145 7 p. 80
  9. Sun X-P et al. Peroxisomal dysfunction and Alzheimer’s disease. (2014) SHENGMING KEXUE YANJIU / LIFE SCIENCE RESEARCH 1007-7847 18 5 465-470
  10. * Boglárka Schilling-Tóth et al. Role of GDF15 in radiosensitivity of breast cancer cells. (2014) CENTRAL EUROPEAN JOURNAL OF BIOLOGY 1895-104X 1644-3632 2391-5412 9 10 982-992
  11. * Campos-Bedolla P et al. Role of the Blood-Brain Barrier in the Nutrition of the Central Nervous System.. (2014) ARCHIVES OF MEDICAL RESEARCH 0188-4409 1873-5487 45 8 610-638
  12. Franco R et al. Successful therapies for Alzheimer’s disease: Why so many in animal models and none in humans?. (2014) FRONTIERS IN PHARMACOLOGY 1663-9812 5 p. 146
  13. ElAli A et al. The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders.. (2014) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 15 6453-6474
  14. Hennebelle M et al. Challenges to determining whether DHA can protect against age-related cognitive decline. (2015) CLINICAL LIPIDOLOGY 1758-4299 1758-4302 10 1 91-102
  15. * Lénárt N et al. Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment. (2015) FLUIDS AND BARRIERS OF THE CNS 2045-8118 12
  16. Teng Edmond et al. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and A beta pathology and modulates A beta oligomerization. (2015) NEUROBIOLOGY OF DISEASE 0969-9961 1095-953X 82 552-560
  17. * Penke Botond et al. Életmód- és táplálkozási-faktorok szerepe az Alzheimer-kór prevenciójában. (2015) BIOKÉMIA: A MAGYAR BIOKÉMIAI EGYESÜLET FOLYÓIRATA 0133-8455 2060-8152 39 4 39-52
  18. * Avdeef A et al. In Vitro Assays for Assessing BBB Permeability: Artificial Membrane and Cell Culture Models. (2015) Megjelent: BLOOD-BRAIN BARRIER IN DRUG DISCOVERY pp. 188-237
  19. * Avdeef A. et al. In Vitro Assays for Assessing BBB Permeability: Artificial Membrane and Cell Culture Models. (2015) Megjelent: Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral ... pp. 188-237
  20. Evans AR et al. Nincs cím. (2015) PROTEOMICS CLINICAL APPLICATIONS 1862-8346 1862-8354 9 9-10 872-884
  21. * Bogar F et al. Opposite effect of Ca2+/Mg2+ ions on the aggregation of native and precursor-derived Aβ42. (2015) STRUCTURAL CHEMISTRY 1040-0400 1572-9001 26 5-6 1389-1403
  22. Fonseca ACRG et al. The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease. (2015) ENDOPLASMIC RETICULUM STRESS IN DISEASES 2300-4266 2 1 67-81
  23. Bhat NR. Vasculoprotection as a convergent, multi-targeted mechanism of anti-AD therapeutics and interventions. (2015) JOURNAL OF ALZHEIMER'S DISEASE 1387-2877 1875-8908 46 3 581-591
  24. * Walter FR et al. A versatile lab-on-a-chip tool for modeling biological barriers. (2016) SENSORS AND ACTUATORS B-CHEMICAL 0925-4005 222 1209-1219
  25. * Helms Hans C. et al. In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. (2016) JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 0271-678X 1559-7016 36 5 862-890
  26. Li Huiyuan et al. Modulation of Amyloid beta-Protein (A beta) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting A beta Toxicity. (2016) ACS CHEMICAL NEUROSCIENCE 1948-7193 7 7 845-856
  27. Rahimi F et al. Modulators of Amyloid β-Protein (Aβ) Self-Assembly. (2016) Megjelent: Developing Therapeutics for Alzheimer's Disease: Progress and Challenges pp. 97-191
  28. Del Brutto OH et al. Oily fish consumption is inversely related with cerebral microbleeds in community-dwelling older adults: results from Atahualpa Project. (2016) AGING CLINICAL AND EXPERIMENTAL RESEARCH 1594-0667 1720-8319 28 4 737-743
  29. * Jähne EA et al. Pharmacokinetics and in vitro blood-brain barrier screening of the plant-derived alkaloid tryptanthrin. (2016) PLANTA MEDICA: NATURAL PRODUCTS AND MEDICINAL PLANT RESEARCH 0032-0943 1439-0221 82 11/12 1021-1029
  30. * Moradi-Afrapoli F et al. Validation of UHPLC-MS/MS methods for the determination of kaempferol and its metabolite 4-hydroxyphenyl acetic acid, and application to in vitro blood-brain barrier and intestinal drug permeability studies. (2016) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 0731-7085 1873-264X 128 264-274
  31. Abdullah L et al. APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer’s Disease. (2017) AGING-US 1945-4589 9 3 964-985
  32. Rege Shraddha D et al. Can Diet and Physical Activity Limit Alzheimer's Disease Risk?. (2017) CURRENT ALZHEIMER RESEARCH 1567-2050 14 1 76-93
  33. Shi L et al. Early interleukin-6 enhances hepatic ketogenesis in APPSWE/PSEN1dE9 mice via 3-hydroxi-3-methylglutaryl-CoA synthase 2 signaling activation by p38/nuclear factor κB p65. (2017) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 56 115-126
  34. * Kiss L et al. In Vitro and In Vivo Blood-Brain Barrier Penetration Studies with the Novel Cyanide Antidote Candidate Dimethyl Trisulfide in Mice. (2017) TOXICOLOGICAL SCIENCES 1096-6080 1096-0929 160 2 398-407
  35. Majerova P et al. Pathophysiology of the Blood-Brain Barrier in Neuroinflammatory Diseases: Chapter 4. (2017) Megjelent: THE BLOOD BRAIN BARRIER AND INFLAMMATION pp. 61-79
  36. Zenaro Elena et al. The blood-brain barrier in Alzheimer's disease. (2017) NEUROBIOLOGY OF DISEASE 0969-9961 1095-953X 107 41-56
  37. * Hoyk Zsófia et al. Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice. (2018) FRONTIERS IN CELLULAR NEUROSCIENCE 1662-5102 12
  38. Sato K.. Consideration for future in vitro bbb models — technical development to investigate the drug delivery to the CNS. (2018) FOLIA PHARMACOLOGICA JAPONICA 0015-5691 152 6 287-294
  39. Du J et al. Importance of extracellular matrix and growth state for the EA.hy926 endothelial cell response to polyunsaturated fatty acids. (2018) PLOS ONE 1932-6203 1932-6203 13 5
  40. Du Y. et al. Importance of extracellular matrix and growth state for the EA.hy926 endothelial cell response to polyunsaturated fatty acids. (2018) PLOS ONE 1932-6203 1932-6203 13 5
  41. * Harazin A et al. Protection of cultured brain endothelial cells from cytokine-induced damage by α-melanocyte stimulating hormone. (2018) PEERJ 2167-8359 6
  42. Petrovic Marko et al. The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma. (2019) SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO 0370-8179 147 5-6 311-315
  43. Jia Y. et al. Alteration in the function and expression of SLC and ABC transporters in the neurovascular unit in alzheimer's disease and the clinical significance. (2020) AGING AND DISEASE 2152-5250 2152-5250 11 2 390-404
  44. Levit A. et al. Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease. (2020) GEROSCIENCE: OFFICIAL JOURNAL OF THE AMERICAN AGING ASSOCIATION (AGE) 2509-2715 2509-2723 42 2 445-465
  45. Raimondi I. et al. Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration. (2020) FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY 2296-4185 7
  46. * Barna Lilla et al. Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.. (2020) FLUIDS AND BARRIERS OF THE CNS 2045-8118 17 1 p. 5
  47. * Ardid-Ruiz A. et al. The effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage. (2020) JOURNAL OF ETHNOPHARMACOLOGY 0378-8741 247
2020-07-13 17:36